BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12687956)

  • 1. [Hepatitis C epidemiology at a general hospital center. Management and natural history as a function of the manner of identification].
    Cadranel JF; Di Martino V; Cesbron H; Cazier A; Demontis R; Coutarel P; Bachmeyer C; Cordier F; Lukumbo S; Fiévet P; Mougeot-Martin M; Van Batten C; Devergie B; Dumouchel P
    Gastroenterol Clin Biol; 2000 Feb; 24(2):161-7. PubMed ID: 12687956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening of patients at risk for hepatitis C virus infection in general medicine].
    Altman C; Lesiour A; Dunbavand A; Meyer L; de la Selle P; Buffet C
    Gastroenterol Clin Biol; 1999 Mar; 23(3):359-62. PubMed ID: 10384340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology of hepatitis C virus infection in 1,304 HCV positive patients: variations according to the origin of transmission and year of diagnosis].
    Guyader D; Lefeuvre C; Jacquelinet S; Prat M; Baudouard Y; Turlin B; André P; Mendler MH; Sapey T; Boucher E; Moirand R; Messner M; Colimon R; Brissot P; Deugnier Y
    Gastroenterol Clin Biol; 1998 Apr; 22(4):375-80. PubMed ID: 9762266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The characteristics of patients with hepatitis C virus antibodies followed in specialized university hospital units are different from those of patients in the general population. The Research Group of the REBOHC].
    Goegebeur G; Benhamiche AM; Minello A; Rassiat E; Clinard F; Milan C; Faivre J; Hillon P
    Gastroenterol Clin Biol; 2000 Nov; 24(11):1042-6. PubMed ID: 11139673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hepatitis C virus infection in the Poitou- Charentes region].
    Frère T; Verneau A; Besson I; de Bayser L; Dupuychaffray JP; Kitmacher P; Silvain C; Beauchant M
    Gastroenterol Clin Biol; 1999; 23(8-9):887-91. PubMed ID: 10533141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes region.
    Defossez G; Verneau A; Ingrand I; Silvain C; Ingrand P; Beauchant M;
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):367-72. PubMed ID: 18403936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
    Hallinan R; Byrne A; Amin J; Dore GJ
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1082-6. PubMed ID: 15955218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care.
    Fireman M; Indest DW; Blackwell A; Whitehead AJ; Hauser P
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S286-91. PubMed ID: 15768336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology and management of care of hepatitis C infection in the Poitou-Charentes region in 1997 and 2000].
    Blanchet E; Defossez G; Verneau A; Ingrand I; Silvain C; Beauchant M;
    Gastroenterol Clin Biol; 2003 Nov; 27(11):1026-30. PubMed ID: 14732849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modalities of care in anti HCV positive patients identified in General Medicine in the Alpes-Maritimes district].
    Ouzan D; Cavailler P; Hofliger P; Mamino C; Joly H; Tran A
    Gastroenterol Clin Biol; 2003 Apr; 27(4):376-80. PubMed ID: 12759676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identified cases of acute hepatitis C from computerized laboratory database: a hospital-based epidemiological and clinical study.
    Hung CH; Lu SN; Wang JH; Hung SF; Chen CH; Hu TH; Lee CM; Changchien CS
    J Infect; 2008 Apr; 56(4):274-80. PubMed ID: 18346790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.
    Fabrizi F; de Vecchi AF; Como G; Lunghi G; Martin P
    Aliment Pharmacol Ther; 2005 Apr; 21(7):861-9. PubMed ID: 15801921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital admission is a relevant source of hepatitis C virus acquisition in Spain.
    Martínez-Bauer E; Forns X; Armelles M; Planas R; Solà R; Vergara M; Fàbregas S; Vega R; Salmerón J; Diago M; Sánchez-Tapias JM; Bruguera M;
    J Hepatol; 2008 Jan; 48(1):20-7. PubMed ID: 17998149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-hepatitis C virus-positive blood donors: are women any different?
    Narciso-Schiavon JL; Schiavon LL; Carvalho-Filho RJ; Freire FC; Cardoso JR; Bordin JO; Silva AE; Ferraz ML
    Transfus Med; 2008 Jun; 18(3):175-83. PubMed ID: 18598280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
    Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection in Egyptian children: single centre experience.
    El-Raziky MS; El-Hawary M; El-Koofy N; Okasha S; Kotb M; Salama K; Esmat G; El-Raziky M; Abouzied AM; El-Karaksy H
    J Viral Hepat; 2004 Sep; 11(5):471-6. PubMed ID: 15357655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
    Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
    Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a hepatitis C screening tool in primary care.
    McGinn T; O'Connor-Moore N; Alfandre D; Gardenier D; Wisnivesky J
    Arch Intern Med; 2008 Oct; 168(18):2009-13. PubMed ID: 18852403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.